BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31611976)

  • 1. Screening and identification of key biomarkers in adrenocortical carcinoma based on bioinformatics analysis.
    Xing Z; Luo Z; Yang H; Huang Z; Liang X
    Oncol Lett; 2019 Nov; 18(5):4667-4676. PubMed ID: 31611976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key genes and pathways in adrenocortical carcinoma: evidence from bioinformatic analysis.
    Yin M; Wang Y; Ren X; Han M; Li S; Liang R; Wang G; Gang X
    Front Endocrinol (Lausanne); 2023; 14():1250033. PubMed ID: 38053725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
    Shi Y; Li Y; Yan C; Su H; Ying K
    Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma.
    Xu WH; Wu J; Wang J; Wan FN; Wang HK; Cao DL; Qu YY; Zhang HL; Ye DW
    Front Genet; 2019; 10():821. PubMed ID: 31572440
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Med Oncol; 2019 Jul; 36(9):73. PubMed ID: 31321566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network analysis reveals potential markers for pediatric adrenocortical carcinoma.
    Kulshrestha A; Suman S; Ranjan R
    Onco Targets Ther; 2016; 9():4569-81. PubMed ID: 27555782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
    Xiao X; Zhang Z; Luo R; Peng R; Sun Y; Wang J; Chen X
    Oncol Lett; 2021 May; 21(5):363. PubMed ID: 33747220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key candidate genes and pathways in anaplastic thyroid cancer by bioinformatics analysis.
    Ding YG; Ren YL; Xu YS; Wei CS; Zhang YB; Zhang SK; Guo CA
    Am J Otolaryngol; 2020; 41(3):102434. PubMed ID: 32093976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and authentication of molecular markers in malignant glioblastoma based on gene expression profiles.
    Zou YF; Meng LB; He ZK; Hu CH; Shan MJ; Wang DY; Yu X
    Oncol Lett; 2019 Nov; 18(5):4593-4604. PubMed ID: 31611967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis.
    Li Z; Sang M; Tian Z; Liu Z; Lv J; Zhang F; Shan B
    Oncol Lett; 2019 Nov; 18(5):4429-4440. PubMed ID: 31611952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatic screening and identification of downregulated hub genes in adrenocortical carcinoma.
    Xu F; Zhang P; Yuan M; Yang X; Chong T
    Exp Ther Med; 2020 Sep; 20(3):2730-2742. PubMed ID: 32765768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key candidate genes for colorectal cancer by bioinformatics analysis.
    Chen Z; Lin Y; Gao J; Lin S; Zheng Y; Liu Y; Chen SQ
    Oncol Lett; 2019 Dec; 18(6):6583-6593. PubMed ID: 31788116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hub genes and key pathways of non-small lung cancer identified using bioinformatics.
    Tang Q; Zhang H; Kong M; Mao X; Cao X
    Oncol Lett; 2018 Aug; 16(2):2344-2354. PubMed ID: 30008938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
    Deng JL; Xu YH; Wang G
    Front Genet; 2019; 10():695. PubMed ID: 31428132
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
    Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
    Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.